Bhatta-Dhar, N
NO DIFFERENCE IN SIX-YEAR BIOCHEMICAL FAILURE RATES WITH OR WITHOUT PELVIC LYMPH NODE DISSECTION DURING RADICAL PROSTATECTOMY IN LOW RISK PATIENTS WITH LOCALIZED PROSTATE CANCER
Urology 2004;63(3):528-531
Bittner, N
Primary causes of death after permanent prostate brachytherapy
IJROBP 2008;72(2):433-440
Boorjian,S
Mayo Clinic Validation of the D'Amico Risk Group Classification for Predicting Survival Following Radical Prostatectomy
J. Urology 2008;179(4):1354-1361
Burri, R
Young men have equivalent biochemical outcomes compares with older men after treatment with brachytherapy for prostate cancer
IJROBP 2010;77(5):1315-21
Busch, J
Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience
BJU Int 2012;110(11):E985-90
Coen, J
Comparison of High-Dose-Rate Proton Radiotherapy and Brachytherapy in Localized Prostate Cancer: A Case-Matched Analysis
IJROBP 2012;82(1):e25-e31
Coen, J
Comparison of High-Dose-Rate Proton Radiotherapy and Brachytherapy in Localized Prostate Cancer: A Case-Matched Analysis
IJROBP 2012;82(1):e25-e31
Critz, F
10-Year disease free survival rates after simultaneous irradiation for prostate cancer with a focus on calulation and methodology
J. Urology 2004;172(6):2232-2338
Critz, FA
25-year disease-free survival rate after irradiation for prostate cancer calculated with the prostat specific antigen definition of recurrences used for radical prostatectomy
J Urol 2013;189(3):878-83
Crouzet, S
Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncological outcomes and morbidity in 1002 patients
Eur Urol 2013;epub Apr 30():
Demanes, D J
Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation
Am J. Clinical Oncology 2009;32(4):342-347
Dickinson, P
Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK.
BJU Int 2014;113(5):748-53
Ding, W
Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy
IJROBP 2012;84(4):962-7
Ellis, R
Ten-year outcomes: the clinical utility of single photon emission computed tomography/computed tomography capromab pendetide (prostascint) in a cohort diagnosed with localized prostate cancer
IJROBP 2010;In Press():
Ganzer, R
Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer.
BJU Int 2013;112(3):322-9
Genebes, C
Conventional versus automated implantation of loose seeds in prostate brachytherapy: analysis of dosimetric and clinical results
IJROBP 2013;87(4):651-58
Hinnen, K
Long-Term Biochemical and Survival Outcome of 921 Patients Treated with I125 Permanent Prostate Brachytherapy
IJROBP 2010;76(5):1433-1438
Jabbari, S
EQUIVALENT BIOCHEMICAL CONTROL AND IMPROVED PROSTATE-SPECIFIC ANTIGEN NADIR AFTER PERMANENT PROSTATE SEED IMPLANT BRACHYTHERAPY VERSUS HIGH-DOSE THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY AND HIGH-DOSE CONFORMAL PROTON BEAM RADIOTHERAPY BOOST
IJROBP 2010;76(1):36-42
Jabbari, S
EQUIVALENT BIOCHEMICAL CONTROL AND IMPROVED PROSTATE-SPECIFIC ANTIGEN NADIR AFTER PERMANENT PROSTATE SEED IMPLANT BRACHYTHERAPY VERSUS HIGH-DOSE THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY AND HIGH-DOSE CONFORMAL PROTON BEAM RADIOTHERAPY BOOST
IJROBP 2010;76(1):36-42
Kane, CJ
Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database
Urology 2010;76(3):695-700
Kuban, D
Long-Term Multi-Institutional Analysis of Stage T1-T2 Prostate Cancer Treated with Radiotherapy in the PSA Era
IJROBP 2003;57(4):915-928
Kupelian,P
Radical Prostatectomy, External Beam Radiotherapy <72 Gy, External Beam Radiotherapy ≥72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer
IJROBP 2004;58(1):25-33
Kupelian,P
Radical Prostatectomy, External Beam Radiotherapy <72 Gy, External Beam Radiotherapy ≥72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer
IJROBP 2004;58(1):25-33
Kupelian,P
Radical Prostatectomy, External Beam Radiotherapy <72 Gy, External Beam Radiotherapy ≥72 Gy, Permanent Seed Implantation, or Combined Seeds/External Beam Radiotherapy for Stage T1-T2 Prostate Cancer
IJROBP 2004;58(1):25-33
Louis, AS
Oncologic outcomes following radical prostatectomy in the active surveillance era.
Can Urol Assoc J 2013;7(7,8):E475-80
Marshall, R
Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-year experience at Mount Sinai Medical Center
Urol Oncol 2013;32(1):38e1-7
Martin, A-G
Permanent Prostate Implant Using High Activity Seeds & Inverse Planning With Fast Simulated Annealing Algorithum: A 12-Year Canadian Experience
IJROBP 2007;67(2):334-341
Menon, M
Biochemical Recurrence Following Robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up
Eur. Urol. 2010;58():838-46
Merrick, G
Prognostic Significance of perineural invasion on biochemical progression-free survival after prostate brachytherapy
J. Urology 2005;66(5):1048-1053
Merrick, G
Androgen deprivation therapy dose not impact cause specific overall survival after permanent prostate brachytherapy
IJROBP 2006;65(3):669-677
Michalski, J
Clinical outcomes of patients treated with 3D conformal radaiation therapy (3D-CRT) for prostate cancer on RTOG 9406.
IJROBP 2012;83(3):e363-70
Morris, WJ
Population-based Study of Biochemical and Survival Outcomes After Permanent 125I Brachytherapy for Low- and Intermediate-risk Prostate Cancer
Urology 2009;73():860-867
Morris, WJ
Population-based 10-year oncological outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer
Cancer 2013;119(8):1537-46
Moyad, M
STATINS, ESPECIALLY ATORVASTATIN, MAY FAVORABLY INFLUENCE CLINICAL PRESENTATION AND BIOCHEMICAL PROGRESSION-FREE SURVIVAL AFTER BRACHYTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER
Urology 2005;66(6):1150-1154
Mullins, JK
Radical Prostatectomy Outcome in Men 65 Years Old or Older With Low Risk Prostate Cancer
J Urol 2012;187(5):1620-25
Mullins, JK
The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary.
J Urol 2012;188(6):2205-10
Nguyen, P
Biochemical recurrence after radical prostatectomy for prevalent versus incident cases of prostate cancer
Cancer 2008;113(11):3146-3152
Ohashi, T
Outcomes following iodine-125 prostate brachytherapy with or without neoadjuvant androgen deprivation
Radiother & Oncol 2013;109():241-45
Pickles, T
Brachytherapy or Conformal External Radiotherapy for Prostate Cancer: A single-Institution Matched Pair Analysis
IJROBP 2010;76(1):43-49
Pickles, T
Brachytherapy or Conformal External Radiotherapy for Prostate Cancer: A single-Institution Matched Pair Analysis
IJROBP 2010;76(1):43-49
Potters, l
12-Year Outcomes Following Permanent Prostate Brachytherapy in Patients With Clinically Localized Prostate Cancer
J. Urology 2005;173():1562-1566
Rice, K
Low risk prostate cancer in men > 70 years old: to treat or not to treat.
Urol Oncol 2013;31(6):755-60
Rossi, C
Conformal Proton Beam Radiation Therapy for Prostate Cancer: Concepts & Clinical Results
Commun Oncol 2007;4():235-240
Sabolch, A
Gleason Pattern 5 is the Greatest Risk Factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation
IJROBP 2011;81(4):e351-60
Sekiguchi, A
125 Iodine monotherapy for Japanese men with low-and intermediate-risk prostate cancer: outcomes after 5-years of follow-up.
J Radiat Res. 2014;55(2):328-33
Sooriakumaran, P
Biochemical Recurrence After Robot-assisted Radical Prostatectomy in a European Single-centre Cohort with a
Minimum Follow-up Time of 5 Years
Eur Urol 2012;62(5):768-74
Spratt, DE
Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer
IJROBP 2013;85(3):686-92
Stone, N
Local control Following Permanent Prostate Brachytherapy: Effect of High Biologically Effective Dose on Biopsy Results and Oncologic Outcomes
IJROBP 2010;76(2):355-360
Sylvester, J
FIFTEEN-YEAR BIOCHEMICAL RELAPSE-FREE SURVIVAL, CAUSE-SPECIFIC SURVIVAL, AND OVERALL SURVIVAL FOLLOWING I125 PROSTATE BRACHYTHERAPY IN CLINICALLY LOCALIZED PROSTATE CANCER: SEATTLE EXPERIENCE
IJROBP 2011;81(2):376-81
Taira, A
Natural History of Clinically Staged Low- and Intermediate Risk Prostate Cancear Treated With Monotherapeutic Permanent Interstitial Brachytherapy
IJROBP 2010;76(2):349-354
Thames, H
Increasing External Beam Dose for T1-T2 Prostate Cancer: Effect on Risk Groups
Int. J. Rad Onc/Bio 2006;65(4):975-981
Thüroff, S
Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years
J Urol 2013;190(2):702-10
Vargas, C
Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapy
Brachytherapy 2013;12(2):120-5
Vora, S
Nine-year outcome and toxicity in patients treated with IMRT for localized prostate cancer
J Urol 2013;In Press(02/06/2013 00:00:00):
Weight, C
Limited pelvic lymph node dissection does not improve biochemical relapse free survival at 10-years after radical prostatectomy in patients with low risk prostate cancer
J. Urology 2008;71(1):141-145
Zelefsky, M J
Comparison of Tumor Control and Toxicity outcomes of High-dose Intensity-modulated Radiotherapy and Brachytherapy for Patients with Favorable Risk Prostate Cancer
Urology 2010;In Press():
Zelefsky, M J
Comparison of Tumor Control and Toxicity outcomes of High-dose Intensity-modulated Radiotherapy and Brachytherapy for Patients with Favorable Risk Prostate Cancer
Urology 2010;In Press():
Zelefsky, M
Long Term Outcome of High Dose Intensity Modulated Radiation Therapy for Patients With Clinically Localized Prostate Cancer
J. Urology 2006;176(4):1415-1419
Zelefsky, m
Five-Year Outcome of Intraoperative Conformal Permanent I-125 Interstitial Implantation for Patients With Clinically Localized Prostate Cancer
IJROBP 2007;67(1):65-70
Zelefsky, m
long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation in biochemical tumor control and distant metastases-free survival outcomes
IJROBP 2008;71(4):1028-1033
Zietman, A
Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adencarcinoma of the Prostate
JAMA 2005;294(10):1233-1276
Zietman, A
Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09
J. Clinical Oncology 2010;28(7):1106-1111